Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges

被引：39

作者：

Cynis, Holger ^{[1
,2
]}

Frost, Jeffrey L. ^{[1
,3
]}

Crehan, Helen ^{[1
]}

Lemere, Cynthia A. ^{[1
]}

机构：

[1] Harvard Med Sch, Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, 77 Ave Louis Pasteur,NRB636, Boston, MA 02115 USA

[2] Fraunhofer Inst Cell Therapy & Immunol, Weinbergweg 22, D-06120 Halle, Germany

[3] Univ Massachusetts, Sch Med, 55 Lake Ave North, Worcester, MA 01605 USA

来源：

MOLECULAR NEURODEGENERATION | 2016年 / 11卷

基金：

美国国家卫生研究院;

关键词：

Amyloid-beta; Pyroglutamate-3 A beta; Immunotherapy; Vaccine; Glutaminyl cyclases; AMYLOID PRECURSOR PROTEIN; TRANSGENIC MOUSE MODEL; MODERATE ALZHEIMERS-DISEASE; PRESENILIN-1; MUTATION; GLUTAMINYL CYCLASES; GAMMA-SECRETASE; PEPTIDE; DEPOSITION; MICE; IMMUNIZATION;

D O I：

10.1186/s13024-016-0115-2

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Immunization against amyloid-beta (A beta) peptides deposited in Alzheimer's disease (AD) has shown considerable therapeutic effect in animal models however, the translation into human Alzheimer's patients is challenging. In recent years, a number of promising A beta immunotherapy trials failed to reach primary study endpoints. Aside from uncertainties in the selection of patients and the start and duration of treatment, these results also suggest that the mechanisms underlying AD are still not fully understood. Thorough characterizations of protein aggregates in AD brain have revealed a conspicuous heterogeneity of A beta peptides enabling the study of the toxic potential of each of the major forms. One such form, amino-terminally truncated and modified pyroglutamate (pGlu)-3 A beta peptide appears to play a seminal role for disease initiation, qualifying it as novel target for immunotherapy approaches.

引用

页数：11

共 84 条

[1] Immunodominant epitope and properties of pyroglutamate-modified Aβ-specific antibodies produced in rabbits [J].

Acero, G. ;

Manoutcharian, K. ;

Vasilevko, V. ;

Munguia, M. E. ;

Govezensky, T. ;

Coronas, G. ;

Luz-Madrigal, A. ;

Cribbs, D. H. ;

Gevorkian, G. .

JOURNAL OF NEUROIMMUNOLOGY, 2009, 213 (1-2) :39-46

[2] An Effector-Reduced Anti-β-Amyloid (Aβ) Antibody with Unique Aβ Binding Properties Promotes Neuroprotection and Glial Engulfment of Aβ [J].

Adolfsson, Oskar ;

Pihlgren, Maria ;

Toni, Nicolas ;

Varisco, Yvan ;

Buccarello, Anna Lucia ;

Antoniello, Katia ;

Lohmann, Sophie ;

Piorkowska, Kasia ;

Gafner, Valerie ;

Atwal, Jasvinder K. ;

Maloney, Janice ;

Chen, Mark ;

Gogineni, Alvin ;

Weimer, Robby M. ;

Mortensen, Deborah L. ;

Friesenhahn, Michel ;

Ho, Carole ;

Paul, Robert ;

Pfeifer, Andrea ;

Muhs, Andreas ;

Watts, Ryan J. .

JOURNAL OF NEUROSCIENCE, 2012, 32 (28) :9677-9689

[3] Selective Hippocampal Neurodegeneration in Transgenic Mice Expressing Small Amounts of Truncated Aβ Is Induced by Pyroglutamate-Aβ Formation [J].

Alexandru, Anca ;

Jagla, Wolfgang ;

Graubner, Sigrid ;

Becker, Andreas ;

Baeuscher, Christoph ;

Kohlmann, Stephanie ;

Sedlmeier, Reinhard ;

Raber, Kerstin A. ;

Cynis, Holger ;

Roenicke, Raik ;

Reymann, Klaus G. ;

Petrasch-Parwez, Elisabeth ;

Hartlage-Ruebsamen, Maike ;

Waniek, Alexander ;

Rossner, Steffen ;

Schilling, Stephan ;

Osmand, Alexander P. ;

Demuth, Hans-Ulrich ;

von Hoersten, Stephan .

JOURNAL OF NEUROSCIENCE, 2011, 31 (36) :12790-12801

[4] Vanutide Cridificar and the QS-21 Adjuvant in Japanese Subjects with Mild to Moderate Alzheimer's Disease: Results from Two Phase 2 Studies [J].

Arai, Heii ;

Suzuki, Hideo ;

Yoshiyama, Tamotsu .

CURRENT ALZHEIMER RESEARCH, 2015, 12 (03) :242-254

[5] Neuropathology after active Aβ42 immunotherapy: implications for Alzheimer's disease pathogenesis [J].

Boche, Delphine ;

Denham, Nathan ;

Holmes, Clive ;

Nicoll, James A. R. .

ACTA NEUROPATHOLOGICA, 2010, 120 (03) :369-384

[6] Inhibition of amyloid beta-protein production in neural cells by the serine protease inhibitor AEBSF [J].

Citron, M ;

Diehl, TS ;

Capell, A ;

Haass, C ;

Teplow, DB ;

Selkoe, DJ .

NEURON, 1996, 17 (01) :171-179

[7] EXCESSIVE PRODUCTION OF AMYLOID BETA-PROTEIN BY PERIPHERAL CELLS OF SYMPTOMATIC AND PRESYMPTOMATIC PATIENTS CARRYING THE SWEDISH FAMILIAL ALZHEIMER-DISEASE MUTATION [J].

CITRON, M ;

VIGOPELFREY, C ;

TEPLOW, DB ;

MILLER, C ;

SCHENK, D ;

JOHNSTON, J ;

WINBLAD, B ;

VENIZELOS, N ;

LANNFELT, L ;

SELKOE, DJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (25) :11993-11997

[8] GENERATION OF AMYLOID-BETA PROTEIN FROM ITS PRECURSOR IS SEQUENCE-SPECIFIC [J].

CITRON, M ;

TEPLOW, DB ;

SELKOE, DJ .

NEURON, 1995, 14 (03) :661-670

[9]

Crehan H, 2015, SOC NEUROSCI

[10]

Crehan H, 2015, 12 INT C ALZH DIS PA

← 1 2 3 4 5 6 7 8 9 →